The New York Mets are taking a chance on a recovering pitcher, sparking curiosity and debate among fans. They've signed Daniel Duarte, a 29-year-old right-handed pitcher, to a minor league contract. But here's the twist: Duarte hasn't pitched since May 2024 due to a UCL revision surgery. This move raises questions about his potential impact and the team's strategy.
Duarte, a veteran of three MLB seasons, had a promising 3.99 ERA in his limited time in the big leagues. However, his strikeout and walk rates paint a different picture, with a low 17% strikeout rate and a concerning 14.5% walk rate. Despite being known for inducing ground balls in the minors, he still managed a 47.3% grounder rate in the majors, but his home run allowance is a cause for concern.
And this is where it gets intriguing: after a long recovery, Duarte dominated in the Mexican winter league, pitching 19 2/3 scoreless innings with impressive control. This performance caught the Mets' attention, who saw potential in his comeback. They brought him to Spring Training, along with other minor league pitchers, with no risk involved.
The Mets' strategy is clear: they want to assess Duarte's progress and give him a shot at earning a spot. With their frequent shuffling of relievers between Triple-A and the active roster, there's a real chance for him to make an impact. Plus, with a minor league option year remaining, Duarte has an edge over other players in the roster competition.
So, will Duarte's comeback story be a success? Can he overcome his injury history and become a reliable reliever for the Mets? The team's decision to sign him is a bold move, and only time will tell if it pays off. What do you think? Is this a smart gamble or a risky move? Share your thoughts in the comments!
